bilaterals.org logo
bilaterals.org logo

medicines


Will the Trans Pacific Partnership have an impact on Indian pharma industry?
Implications of the TPP on the Indian pharma industry might not be entirely clear yet. But there is a need for India to engage in the debate of trade deals and public interest.
ATL MST Sida-Tunis tire la sonnette d’alarme : l’accès des Tunisiens aux médicaments en danger
Les conséquences des dispositions relatives à la propriété intellectuelle contenues dans l’accord signé entre l’Union Européenne et la Tunisie et leurs conséquences sur la santé publique en Tunisie inquiètent.
India must resist US pressure on generic drugs, African leaders to tell Modi
So far, the NDA government has been a mute spectator to the US pharma strategy of forcing Indian generics manufacturers to produce only what is required for Indian consumers and abandon the export of cheap drugs to Africa
USITC Report on India (#2) now available
The United States International Trade Commission (USITC) has published a report on IPR policy transparency by India’s new government
The problem with tying health care to trade
Writing pharmaceutical regulations into international trade deals can have costly consequences.
What the Trans-Pacific Partnership means for the cost of drugs
A quick analysis of the leaked text shows there are good reasons to be concerned that the TPP’s generous IP protections could still prove a minefield for efforts to control drug costs in Canada
Drugs row threatens health sector budget
Ahead of a meeting between Indian Prime Minister Modi and German Chancellor Merkel this week, European manufacturers had already protested India’s patents policy, arguing that it doesn’t protect sensitive technology.
Preliminary comments on the completed Trans Pacific Partnership (TPP) intellectual property chapter
The TPP’s intellectual property chapter represents nothing less than a disaster for global health. Many harmful provisions still remain in the final chapter, bearing out the concerns of public health advocates.
Doctors without borders blasts TPP’s impact on life-saving drugs
The TPP could give pharmaceutical corporations more power to control medicine markets and “impose higher prices for longer.”
Secret Trans - Pacific (TPP) deal lacks detail on medicines, includes corporate rights to sue governments
The lack of access to details in the text means governments can put a positive spin on the deal, but the devil is in the detail.
Trans-Pacific Partnership: ’50/50’ chance of trade deal today as negotiators lock horns over medical patent protection
Australia — along with others such as New Zealand and Chile — has been unwilling to offer more than five years protection for the medicines, because longer terms would increase the cost of state-subsidised medical programs.
U.S., Australia agree on complicated compromise on biologic drugs
Countries in the trade bloc would have an alternative of either providing eight years of exclusivity to biologic drugs, or providing five years of so-called data exclusivity plus up to three more years under a regulatory framework in the TPP.
US, Australia drug dispute is holding up settlement of the Trans Pacific trade deal
A standoff between Australia and the United States on monopoly rules for pharmaceutical drugs has emerged as the ultimate impediment to clinching an historic trade deal sweeping across 12 Pacific Rim countries.
Latest TIFA talks ’productive’: US
The latest round of trade talks between Taiwan and the U.S. under the bilateral Trade and Investment Framework Agreement (TIFA) made much ground in a number of areas but both sides have yet to reach consensus on issues such as U.S. pork imports.
TIFA talks ignore interests of ordinary citizens: groups
The latest round of Trade and Investment Framework Agreement (TIFA) talks with the US ignores the interests of ordinary citizens, labor activists said yesterday.
TPP trade talks extended as negotiators struggle for a deal
The talks remained bogged down after two days of negotiations between ministers from the United States, Japan, Australia and nine other countries over a handful of sticky issues.
Nouvelle tentative pour conclure l’accord commercial trans-pacifique (TPP)
Les représentants de 12 pays riverains du Pacifique se réunissent à Atlanta pour tenter de parvenir à une entente sur un vaste accord commercial, connu sous son acronyme TPP.
Auto, dairy, drug issues arrest TPP talks
Major challenges in three areas remain in concluding the Trans-Pacific Partnership, according to officials involved in the discussions.
Cancer patient disrupts TPP negotiations
Arrested from hotel demanding to see the secret "death sentence clause"
Corporate power unbound: investor-state arbitration of IP monopolies on medicines - Eli Lilly v. Canada and the Trans-Pacific Partnership agreement
Despite the deep irony of free trade agreements being subverted to codify and extend anti-competitive monopoly rights the joining of enhanced intellectual property rights (IPRs) and strengthened investor rights is creating a wild-west opportunity for unbounded corporate power.